Biotech Firm Hayashibara To Go For ADR Turnaround Process

Hayashibara Co., a Okayama-based biotechnology company, announced it will enter an alternative dispute resolution (ADR) process with more than 30 creditors regarding debt totaling as much as 140 billion yen. The firm, known for its sweeteners and anti-cancer researches, announced later that it was proud of its 28 billon yen in sales in 2010.